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Abstract 
 
The Diabetes Virus Detection study (DiViD) is the first to examine fresh pancreatic tissue at 
the diagnosis of type 1 diabetes for the presence of viruses. Minimal pancreatic tail resection 
was performed 3-9 weeks after onset of type 1 diabetes in 6 adult patients (age 24-35 years). 
The presence of enteroviral capsid protein 1 (VP1) and the expression of class I HLA were 
investigated by immunohistochemistry. Enterovirus RNA was analyzed from isolated 
pancreatic islets and from fresh frozen whole pancreatic tissue using PCR and sequencing. 
Non-diabetic organ donors served as controls. VP1 was detected in the islets of all type 1 
diabetes patients (2 of 9 controls). Hyperexpression of class I HLA molecules was found in 
the islets of all patients (1 of 9 controls). Enterovirus specific RNA sequences were detected 
in 4 of 6 cases (0 of 6 controls). The results were confirmed in different laboratories. Only 
1.7 % of the islets contained VP1 positive cells and the amount of enterovirus RNA was low. 
The results provides evidence for the presence of enterovirus in pancreatic islets of type 1 
diabetic patients, being consistent with the possibility that a low grade enteroviral infection in 
the pancreatic islets contribute to disease progression in humans.  
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Despite intensive research efforts over the past century, the precise causes of type 1 diabetes 
are still unknown although it is well established that the illness results from a complex 
interplay between genetic predisposition, the immune system and various environmental 
factors (1). One such influence is viral infection, first postulated in 1927 by Gundersen (2), 
who observed an increase in the incidence of type 1 diabetes following epidemics of mumps. 
Since then numerous studies have addressed the possible role of viruses as causative agents in 
type 1 diabetes and it has emerged that infection with enteroviruses provides association with 
disease development (3-6). Nevertheless the question of causality remains open and data 
which confirm the presence of enterovirus in the pancreases of type 1 diabetic patients would 
significantly strengthen the conclusions.  
 
One of the principal factors limiting progress in the field has been the lack of availability of 
well-preserved tissue samples for study (7). The majority of published studies have made use 
of pancreatic tissues collected at autopsy from type 1 diabetic patients having varying 
duration of diabetes (8-10). Much of the material has been affected by post-mortem changes 
and preserved in the form of formalin-fixed, paraffin-embedded blocks, which means that 
many of the more modern techniques used to detect viruses cannot be applied with 
confidence. It would be preferable if well-preserved human organ samples could be accessed, 
since these should be more amenable to the detection of viral RNA sequences, viral antigen 
production and the cellular responses to viral infection (11). 
 
The main objective of the Diabetes Virus Detection-study (DiViD) was to collect pancreatic 
tissue from living subjects very soon after the diagnosis of type 1 diabetes to investigate the 
presence of viruses. The sampling procedures and clinical data from the recruited patients 
have been reported (12). Here we provide evidence that the islets of Langerhans of these 
 
 
4 
 
patients display features consistent with a low-grade enteroviral infection. The study was 
approved by the Government’s Regional Ethics Committee in Norway. 
 
Material and methods 
A total of six type 1 diabetic patients (three women, three men), age 24-35 years (median 28 
years) were recruited to the study after giving written informed consent. Pancreatic biopsies, 
approximately 3 cm of the tail, were taken 3-9 weeks after diagnosis of type 1 diabetes 
(median five weeks). Details regarding the patients are shown in Table 1. 
 
The biopsies were processed under sterile conditions and immediately divided into multiple 
smaller pieces snap-frozen in liquid nitrogen in the operating theatre (Table 1) and 
subsequently stored at -80 
o 
C. Formalin fixed, paraffin embedded tissue blocks were prepared 
simultaneously. Other parts were allocated for the purification of living pancreatic islets in 
ViaSpan© medium. Nine otherwise healthy, non-diabetic, cadaver Caucasian organ-donors 
(two women, seven men, age range 18-38, mean 25.2) collected by the network for pancreatic 
organ donors (nPOD) were used as controls for IHC analyses, all being negative for anti-
GAD, IA2, insulin and ZnT8 autoantibodies. In addition, six non-diabetic organ-donors from 
Uppsala (age range 55-70, median 67) also negative for anti-GAD and IA2 were used as 
methodological controls in virus detection from isolated islets using PCR. Demographic 
details regarding age, sex, BMI and auto-antobodies and HLA of the controls are shown in 
eTable 1. 
  
Islet isolation 
Pancreatic islets were isolated in Uppsala using methods previously developed for clinical 
islet isolation (13). Isolated islets were cultured for a few days and aliquots of the culture 
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medium were collected 1, 3, and 6 days post isolation for enterovirus PCR analyses. For 
practical reasons, the PCR-studies were not blinded, but both the cases and controls were 
studied in parallel in the same PCR runs in two laboratories (Uppsala and Tampere). 
 
Detection of enterovirus 
Immunostaining with clone 5D8/1 (Dako, Glostrup, Denmark) to detect enterovirus capsid 
protein 1 (VP1) was performed in two laboratories (Tampere and Exeter). Consecutive four 
μm sections from two different paraffin blocks from each of the cases and from one block 
from each of the controls were processed and labelled using a standard immunoperoxidase 
technique for formalin-fixed paraffin-embedded sections. For details regarding the methods, 
see supplementary material.  
 
Results 
All six type 1 diabetic patients were positive for enterovirus in the endocrine pancreas by at 
least one of the three methods used to detect either viral protein or RNA (Table 2). Four 
patients were enterovirus positive in the pancreas by two methods, one with three methods. 
 
Detection of enterovirus genome 
Enterovirus RNA was detected in the enriched islet preparation in three of the six type 1 
diabetes patients using RT-PCR in both the Uppsala and Tampere laboratories. Virus was 
detected in the medium harvested from islet cultures on days one and/or three, but not on day 
six (Table 2). In addition, islet culture medium from one patient was detected as positive on 
day three in Tampere, and this patient was also positive in the remaining enriched exocrine 
cells, also containing some islets, in Uppsala. None of the islet cultures from six non-diabetic 
controls were enterovirus positive. A snap-frozen pancreas sample containing 30 mg of whole 
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tissue was enterovirus positive in one of the diabetics in both laboratories. The same patient 
was also virus positive in the enriched islets and exocrine cell fractions as described above 
(Table 2). The amount of enterovirus RNA was low in all positive samples. The viral genome 
was partially sequenced in all four virus positive cases and the sequence showed perfect 
match with enterovirus sequences (Table 3). Due to the low virus titer we were able to 
sequence only the conserved region of the genome. Therefore the exact genotype of the virus 
could not be identified. All cases and controls were PCR negative for rhinovirus, norovirus, 
rotavirus, and parechovirus in both islet enriched islets and exocrine cells as well as in snap-
frozen whole tissue samples. High-throughput sequencing of total RNA extracted from whole 
frozen tissue from each patient did not detect any viral sequences.  
 
Detection of enterovirus protein  
Pancreatic islets from all six type 1 diabetes patients were immunopositive for VP1 (Table 2), 
whereas this protein was detected in two of nine controls (100% vs. 22%; p < 0.01). Only 
1.7% of the patient islets contained intense VP1+ cells (42 islets out of a total number of 2492 
islets; immunostaining of consecutive sections for insulin and glucagon and for VP1). 
Altogether 60 intense VP1+ cells were identified in the islets. 
 
Expression of class I HLA molecules  
Hyperexpression of HLA class I molecules was observed homogeneous in the islets of all six 
type 1 diabetes patients but in only one of the nine controls (p < 0.01) (Table 2). Among the 
six patients, all insulin containing islets showed HLA-class I hyper expression irrespective of 
the presence of enterovirus VP1 protein. Figures 1 shows an insulin-containing islet with 
hyper expression of HLA class I and the presence of enterovirus VP1 protein. 
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Discussion  
This study of fresh pancreatic tissue collected close to the time of diagnosis of type 1 diabetes 
suggests that a low-grade enteroviral infection is sustained within the islets of Langerhans. 
Thus, enterovirus RNA was amplified successfully by RT-PCR from four of the six patients 
in two independent laboratories. The presence of enterovirus sequences was also confirmed 
by sequencing the PCR products. Moreover, the enterovirus capsid protein VP1 was detected 
immunohistochemically in islet cells of all six patients. The expression of VP1 is known to be 
most intense during the acute phase of an enterovirus infection (14) while it is reduced during 
persistent infection (15). This is because enteroviral persistence is characterized by naturally-
occurring deletions at the 5′ terminus of the genome (16;17), which reduce the replication rate 
of the virus. It is recently shown that these terminally deleted viruses also can persist after 
inoculation in murine pancreas in the absence of cytopathic virus weeks past the acute 
infectious period (16). Hence, these results are consistent with the possibility that a low-grade 
enterovirus infection had been established and maintained in the islet cells of the patients with 
type 1 diabetes. The biopsies were taken from the pancreatic tail, not discarding that the 
infection could be affecting other parts first slowly disseminating to the rest of tissue. The 
lack of virus induced cytopathic effects in islets and exocrine cell clusters during 3-5 days of 
culture, indicate that the virus is not powerfully cytolytic. This implies that the virus might be 
rendered replication deficient during the development of a persistent infection.  
 
It is well understood that the amplification achieved by PCR allows for the detection of even 
very small quantities of target RNA and it is thus significant that four of the type 1 diabetes 
patients were positive for viral RNA when analyzed by RT-PCR in two different laboratories. 
The detection of positive signals required as many as 40 cycles of amplification or the use of a 
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nested RT-PCR method, indicating that only very small amounts of viral RNA were present. 
Sequencing confirmed that amplified sequences originated from enteroviruses. 
 
The high sensitivity of PCR makes it susceptible for wrong positive results due to viruses 
which may contaminate the samples during the analysis. Several actions were taken to avoid 
such contaminations and to be able to detect them if they occur. First, the two virus 
laboratories got the same results even if they carried out all RNA extraction and RT-PCR 
steps independently and used different primers and PCR protocols. Second, the amplified 
enterovirus sequences differed from each other suggesting that they originate from different 
enterovirus strains thus excluding a common contaminating virus. Third, exocrine cells which 
were isolated from the same pancreases in the same time and place, as well as virus negative 
internal control samples included in each test run, were all PCR negative. In addition, all 
pancreas samples were PCR negative for all other tested viruses. Finally, control pancreases 
from non-diabetic individuals were PCR negative even if they were processed using exactly 
the same procedures and in the same laboratory as the samples from diabetic patients. 
 
The antibody used to detect VP1 is known to recognize this protein from multiple different 
enteroviruses in formalin fixed samples (18). However, it has also been shown that, under 
some conditions, the antibody may label certain human proteins (19). We were careful to 
employ the antibody under conditions optimized to avoid such interactions without 
compromise of virus-specific binding (20). Thus, we are confident that the immunolabelling 
achieved in human pancreas sections is likely to represent the presence of viral protein.  
 
In addition to virus specific markers, the expression of class I HLA molecules was 
upregulated in the islets of all type 1 diabetes patients. This fits with previous observations 
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showing that pancreatic islets of type 1 diabetes patients hyperexpress class I HLA molecules 
and interferon-alpha (21;22). This might indicate ongoing virus-induced interferon secretion 
in the islets. We have previously shown that enterovirus infection in human pancreatic islets 
leads to such HLA class I hyperexpression in vitro, partly mediated by secretion of type 1 
interferon’s (23). 
 
This study did not include pancreatic biopsies from healthy living individuals. Although not 
ideal, the non-diabetic organ donors from nPOD are clinically well defined and age matched 
to the cases. The mean age of the subjects from whom islets were isolated for the culture 
studies was higher than the cases, but we would emphasize that these were processed as the 
cases and served mainly as methodological controls in PCR analyses being negative for all 
tested viruses in PCR.  
 
In conclusion, DiViD is the first study of living newly diagnosed type 1 diabetic patients 
demonstrating the presence of enterovirus in pancreatic islets using multiple techniques across 
several independent laboratories including the detection of enterovirus specific sequences in 
the islets. The results do not prove causality between enterovirus infection and type 1 diabetes 
but they support the view that a low grade enteroviral infection is present in the islets of 
Langerhans at diagnosis of type 1 diabetes. These findings should encourage studies in which 
anti-viral medication and/or vaccines against enteroviruses could be tested to reduce disease 
progression and prevent type 1 diabetes.  
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Table 1 Clinical data of cases with newly diagnosed type 1 diabetes. 
Case Age Sex BMI 
Weeks 
from 
diagnosis 
until 
biopsy 
HbA1c 
at 
biopsy 
% 
(mmol/ 
mol) 
Insulin 
(U/kg/ 
day) 
Anti 
GAD 
(<0.08 
ai) 
Anti-
insulin 
(<0.08 
ai) 
anti-
ZnT8 
(<0.12 
ai) 
Anti IA2 
(< 0.10 
ai*) 
HLA 
risk 
alleles† 
Seconds until 
snap-freezing 
of pancreatic 
tissue 
1 25 F 21.0 4 6.7 (50) 0.5 1.76 0.7 0.28 0.16 Yes 110 
2 24 M 20.9 3 
10.3 
(89) 
0.35 0.79 <0.01 0.44 >3 Yes 150 
3 34 F 23.7 9 7.1 (54) 0.17 1.77 < 0.05 1,.45 > 3 Yes 150 
4 31 M 25.6 5 7.4 (57) 0.4 0.77 0.1 < 0.01 2.54 Yes 160 
5 24 F 28.6 5 7.4 (57) 0.36 0.46 0.1 0.06 >3 Yes 240 
6 35 M 26.7 5 7.1 (54) 0.52 1.85 < 0.05 < 0.01 < 0.04 Yes 190 
* Arbitrary units according to Diabetes Antibody Standardization Program (DASP) (24) 
† Presence of HLA DR3-DQ2, HLA DR4-DQ8, or both 
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Table 2 Detection of enterovirus protein, enterovirus RNA and expression of class 1 HLA 
molecules in the pancreas of newly diagnosed type 1 diabetic patients. 
 
 
 
Enterovirus VP1 
protein expression 
Enterovirus genome 
Class I HLA 
expression  
Methodology IHC Enterovirus specific RT-PCR RNA 
sequencing 
IHC 
Tissues Pancreatic islets 
Supernatant from 
cultured purified 
pancreatic islets 
Snap-frozen 
pancreas  
30 mg  
Snap-frozen 
pancreas  
30 mg 
Pancreatic 
islets 
Laboratory 
Tampere Exeter Uppsala Tampere 
Tampere 
and Uppsala 
Oslo Exeter 
Case 
1 Positive Positive Negative Negative Negative Negative 
Hyper 
expression 
2 Positive Positive Positive * Positive † Negative Negative 
Hyper 
expression 
3 Positive Positive Negative Negative Negative Negative 
Hyper 
expression 
4 Positive Negative Positive * Positive † Negative Negative 
Hyper 
expression 
5 Positive Positive Positive ‡ Positive ‡ Negative Negative 
Hyper 
expression 
6 Positive Positive Negative§ Positive ‡ Positive Negative 
Hyper 
expression 
 
* 
Positive day 1 and 3 
† Positive day 1 
‡
 Positive day 3 
§ Positive in RNA extracted from culturing of the remaining cells, containing both exocrine 
and unknown number of islets 
 
 
 
17 
 
Table 3. Sequence alignment of PCR-products, Uppsala. Variable nucleotide sites between 
different cases are highlighted with yellow. 
 
 
Figure 1 Pancreatic islet from one of type 1 diabetic patient , stained for insulin (brown) and 
glucagon (red) (A), HLA class 1 molecules (B) and enterovirus protein VP1 (C). (Cells 
positive for enterovirus protein are marked by arrows) 
A.    B.    C. VP1-positive cells. 
 
 
